| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 |
| Phrase | Consultant | Town | Special Interests |
| Lymphoma/haematological oncology | *Consultant(s)* | *Towns* | Lymphoma/haematological oncology, stem cell transplantation |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, breast cancer pharmacogenetics |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, urological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancer, gynaecological cancer, cancers of unknown primary |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, prostate cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, breast cancer, gastrointestinal tumours |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, gastrointestinal cancer, colorectal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, acute oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, cellular therapy |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma, breast cancer, gastrointestinal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancer, hepatopancreatobiliary cancer, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, urological cancers, penile and testicular cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, urological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, pancreatic cancer, gastrointestinal cancer, neuroendocrine tumours, early phase clinical trials |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, breast disease, upper gastrointestinal cancer, neuroendocrine tumours, chemotherapy |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, fertility after a diagnosis of breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, breast, upper gastrointestinal |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancer, urological cancers |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, cancer drug development, phase 1 - 2 trials |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, colorectal cancer, lung cancer, mesothelioma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, clinical trials, cancer therapeutics, drug development |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, urological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, melanoma, colorectal oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, neuroendocrine cancer, colorectal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, pancreatic cancer, experimental cancer therapeutics |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, upper gastrointestinal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancer, urological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancer, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, soft tissue sarcoma, chemotherapy |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast, lung and upper gastrointestinal cancers, cancers of unknown primary |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, melanoma, ovarian cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, mesothelioma, thymoma, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, chemotherapy, acute oncology, breast cancer, targeted treatment for metastatic melanoma, melanoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, renal cell carcinoma, thoracic malignancies |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lymphomas, HIV malignancies |
| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 |
